Involvement of 5-HT1A and GABAA receptors in the anxiolytic-like effects of Cinnamomum cassia in mice

Pharmacology Biochemistry and Behavior

Volumn 87, Issue 1, 2007, Pages 164-170

  Yu, Hyun Sook ^a   Lee, Seok Yong ^a   Jang, Choon Gon ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

5 HT1A receptor; Anxiolytic like effect; Benzodiazepine receptor; Cinnamomum cassia; Elevated plus maze; GABAA receptor

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE RECEPTOR; CINNAMOMUM CASSIA EXTRACT; DIAZEPAM; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ALCOHOL; ANXIOLYTIC AGENT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; BICUCULLINE; CENTRAL MUSCLE RELAXANT; FLUMAZENIL; PIPERAZINE DERIVATIVE; PLANT EXTRACT; PYRIDINE DERIVATIVE; SEROTONIN ANTAGONIST; SOLVENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CINNAMOMUM CASSIA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; LOCOMOTION; MALE; MAZE TEST; MOUSE; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; REPEATED DRUG DOSE; SEROTONINERGIC SYSTEM; SINGLE DRUG DOSE; TRANQUILIZING ACTIVITY; ANIMAL; BODY EQUILIBRIUM; CHEMISTRY; CINNAMOMUM; INSTITUTE FOR CANCER RESEARCH MOUSE; MOTOR ACTIVITY;

CINNAMOMUM AROMATICUM; MUS;

ANIMALS; ANTI-ANXIETY AGENTS; BICUCULLINE; CINNAMOMUM; ETHANOL; FLUMAZENIL; GABA ANTAGONISTS; GABA MODULATORS; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; MUSCLE RELAXANTS, CENTRAL; MUSCULOSKELETAL EQUILIBRIUM; PIPERAZINES; PLANT EXTRACTS; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, GABA-A; SEROTONIN ANTAGONISTS; SOLVENTS;

EID: 34249783909     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.04.013     Document Type: Article

References (33)

1. Ballenger J.C. Treatment of anxiety disorders to remission. J Clin Psychiatry 62 Suppl 12 (2001) 5-9
2. Beck A.T. Cognitive approaches to panic disorder: theory and therapy. In: Maser J.D., and Rachman S. (Eds). Panic: Psychological Perspective (1988), Lawrence Erlbaum Associates, Hillsdale 91-109
3. Blier P., Lista A., and De M.C. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins. J Pharmacol Exp Ther 265 (1993) 16-23
4. Briley M., Chopin P., and Moret C. Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology (Berl) 101 (1990) 187-189
5. 1A antagonist, WAY 100635. Psychopharmacology (Berl) 132 (1997) 35-43
6. Delaney A.J., and Sah P. GABA receptors inhibited by benzodiazepines mediate fast inhibitory transmission in the central amygdala. J Neurosci 19 (1999) 9698-9704
7. Eguchi J., Inomata Y., and Saito K. The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism. Pharmacol Biochem Behav 68 (2001) 677-683
8. File S.E. Recent developments in anxiety, stress, and depression. Pharmacol Biochem Behav 54 (1996) 3-12
9. Helton D.R., Berger J.E., Czachura J.F., Rasmussen K., and Kallman M.J. Central nervous system characterization of the new cholecystokininB antagonist LY288513. Pharmacol Biochem Behav 53 (1996) 493-502
10. Hui K.M., Huen M.S., Wang H.Y., Zheng H., Sigel E., Baur R., et al. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem Pharmacol 64 (2002) 1415-1424
11. Huss U., Ringbom T., Perera P., Bohlin L., and Vasange M. Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay. J Nat Prod 65 (2002) 1517-1521
12. Imaizumi M., and Onodera K. Animal models of 'anxiety'. Nippon Yakurigaku Zasshi 115 (2000) 5-12
13. Johnson M.R., Marazziti D., Brawman-Mintzer O., Emmanuel N.P., Ware M.R., Morton W.A., et al. Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia. Biol Psychiatry 43 (1998) 306-309
14. A receptor pharmacology. Pharmacol Ther 69 (1996) 173-198
15. Jung J.W., Cho J.H., Ahn N.Y., Oh H.R., Kim S.Y., Jang C.G., et al. Effect of chronic Albizzia julibrissin treatment on 5-hydroxytryptamine1A receptors in rat brain. Pharmacol Biochem Behav 81 (2005) 205-210
16. Jung J.W., Yoon B.H., Oh H.R., Ahn J.H., Kim S.Y., Park S.Y., et al. Anxiolytic-like effects of Gastrodia elata and its phenolic constituents in mice. Biol Pharm Bull 29 (2006) 261-265
17. Kawahara H., Yoshida M., Yokoo H., Nishi M., and Tanaka M. Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis. Neurosci Lett 162 (1993) 81-84
18. Kim W.K., Jung J.W., Ahn N.Y., Oh H.R., Lee B.K., Oh J.K., et al. Anxiolytic-like effects of extracts from Albizzia julibrissin bark in the elevated plus-maze in rats. Life Sci. 75 (2004) 2787-2795
19. Korpi E.R., Grunder G., and Luddens H. Drug interactions at GABA(A) receptors. Prog Neurobiol 67 (2002) 113-159
20. Kurokawa M., Kumeda C.A., Yamamura J., Kamiyama T., and Shiraki K. Antipyretic activity of cinnamyl derivatives and related compounds in influenza virus-infected mice. Eur J Pharmacol 348 (1998) 45-51
21. 1A autoreceptor sensitivity in the rat dorsal raphe nucleus-in vitro electrophysiological evidence. Fundam Clin Pharmacol 11 (1997) 206-214
22. Lader M. Clinical pharmacology of anxiolytic drugs: past, present and future. Adv Biochem Psychopharmacol 48 (1995) 135-152
23. Lee C.W., Hong D.H., Han S.B., Park S.H., Kim H.K., Kwon B.M., et al. Inhibition of human tumor growth by 2'-hydroxy- and 2'-benzoyloxycinnamaldehydes. Planta Med 65 (1999) 263-266
24. Lee H.S., and Ahn Y.J. Growth-inhibiting effects of Cinnamomum cassia bark-derived materials on human intestinal bacteria. J Agric Food Chem 46 (1998) 8-12
25. A receptors. Neuropharmacology 51 (2006) 168-172
26. A receptors. Brain Res Brain Res Rev 29 (1999) 196-217
27. Okazawa H., Yamane F., Blier P., and Diksic M. Effects of acute and chronic administration of the serotonin1A agonist buspirone on serotonin synthesis in the rat brain. J Neurochem 72 (1999) 2022-2031
28. Sandford J.J., Argyropoulos S.V., and Nutt D.J. The psychobiology of anxiolytic drugs. Part 1: Basic neurobiology. Pharmacol Ther 88 (2000) 197-212
29. Sharp T., Bramwell S.R., and Grahame-Smith D.G. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 96 (1989) 283-290
30. Short K.R., and Maier S.F. Stressor controllability, social interaction, and benzodiazepine systems. Pharmacol Biochem Behav 45 (1993) 827-835
31. Sieghart W. Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol Rev 47 (1995) 181-234
32. Wheatley D. Use of anti-anxiety drugs in the medically ill. Psychother Psychosom 49 (1988) 63-80
33. Yoon B.H., Choi J.W., Jung J.W., Shin J.S., Hyeon S.Y., Cheong J.H., et al. Anxiolytic-like effects of phenylpropanoids using the elevated plus-maze in mice. Yakhak Hoeji 49 (2005) 437-442